 1832 Asset Management L.P. purchased a new stake in Alnylam Pharmaceuticals, Inc. NASDAQ:ALNY during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 20,900 shares of the biopharmaceutical companys stock, valued at approximately 2,290,000. Several other institutional investors have also recently made changes ... 